Stenotrophomonas maltophilia, Burkholderia cepacia complex, Elizabethkingia spp.,
Chryseobacterium spp., Achromobacter spp., and Alcaligenes spp. are less‐common non–lactose‐…

Background COVID-19 Convalescent plasma (CCP) is safe and effective, particularly if
given at an early stage of the disease. Our study aimed to identify an association between …

Background: An increasing number of observational studies have reported the persistence
of symptoms following recovery from acute COVID-19 disease in non-cancer patients. The …

Background: In this international multicenter study, we aimed to determine the independent
risk factors associated with increased 30 day mortality and the impact of cancer and novel …

Ceftazidime-avibactam is used clinically in combination with a polymyxin for the treatment of
carbapenem-resistant Gram-negative infections; however, there are limited data to support …

Objectives To characterize a bla CMY variant associated with ceftazidime/avibactam
resistance from a serially collected Escherichia coli isolate. Methods A patient with an intra-…

Antimicrobial resistance (AMR) continues to serve as a major global health crisis. Clinicians
practising in this modern era are faced with ongoing challenges in the therapeutic …

Purpose: To summarize the top 10 most influential peer-reviewed infectious diseases (ID)
pharmacotherapy articles published in the year 2018. Summary: Members of the Houston …

β-Lactamases can accumulate stepwise mutations that increase their resistance profiles to
the latest β-lactam agents. CMY-185 is a CMY-2-like β-lactamase and was identified in an …

Background The IL-6 inhibitor Tocilizumab (TOCI) has been associated with infections in 5-8%
of patients with Rheumatoid Arthritis. TOCI has now been recommended as a treatment …